H2N2V1, PubMed, Curation, bibRecord, 000455

Vaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes.

Identifieur interne : 000455 ( PubMed/Curation ); précédent : 000454; suivant : 000456

Vaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes.

Auteurs : I N Mbawuike [États-Unis] ; H R Six ; T R Cate ; R B Couch

Source :

Journal of virology [ 0022-538X ] ; 1990.

RBID : pubmed:2304146

Descripteurs français

English descriptors

KwdEn :
- Animals, Animals, Newborn, Antibodies, Viral (analysis), Cross Reactions, Female, Immunity, Maternally-Acquired, Influenza A virus (immunology), Mice, Mice, Inbred Strains, Neutralization Tests, Orthomyxoviridae Infections (immunology), Orthomyxoviridae Infections (prevention & control), Pregnancy, Pregnancy, Animal (immunology), Species Specificity, Vaccination, Vaccines, Attenuated.
MESH :
- chemical , analysis : Antibodies, Viral.
- immunology : Influenza A virus, Orthomyxoviridae Infections, Pregnancy, Animal.
- prevention & control : Orthomyxoviridae Infections.
- Animals, Animals, Newborn, Cross Reactions, Female, Immunity, Maternally-Acquired, Mice, Mice, Inbred Strains, Neutralization Tests, Pregnancy, Species Specificity, Vaccination, Vaccines, Attenuated.

Abstract

A single intraperitoneal injection of pregnant mice with a monovalent Formalin-inactivated influenza A virus vaccine protected their offspring against a lethal challenge dose of the same influenza A virus H3N2, H2N2, and H1N1 subtypes, as well as against challenge with the other two subtypes. Degree of protection was vaccine dose related. Cross-fostering of neonates indicated that protection was conferred by breast milk antibodies. Serum virus-specific neutralizing antibodies in the mothers and neonates correlated with resistance to vaccine virus, but were detected against other subtypes only in a complement enhancement test or when high doses of vaccine were given.

PubMed: 2304146

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000455

Links to Exploration step

pubmed:2304146

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Vaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes.</title>
<author><name sortKey="Mbawuike, I N" sort="Mbawuike, I N" uniqKey="Mbawuike I" first="I N" last="Mbawuike">I N Mbawuike</name>
<affiliation wicri:level="2"><nlm:affiliation>Influenza Research Center, Baylor College of Medicine, Houston, Texas 77030.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>Influenza Research Center, Baylor College of Medicine, Houston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Six, H R" sort="Six, H R" uniqKey="Six H" first="H R" last="Six">H R Six</name>
</author>
<author><name sortKey="Cate, T R" sort="Cate, T R" uniqKey="Cate T" first="T R" last="Cate">T R Cate</name>
</author>
<author><name sortKey="Couch, R B" sort="Couch, R B" uniqKey="Couch R" first="R B" last="Couch">R B Couch</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1990">1990</date>
<idno type="RBID">pubmed:2304146</idno>
<idno type="pmid">2304146</idno>
<idno type="wicri:Area/PubMed/Corpus">000455</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000455</idno>
<idno type="wicri:Area/PubMed/Curation">000455</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000455</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Vaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes.</title>
<author><name sortKey="Mbawuike, I N" sort="Mbawuike, I N" uniqKey="Mbawuike I" first="I N" last="Mbawuike">I N Mbawuike</name>
<affiliation wicri:level="2"><nlm:affiliation>Influenza Research Center, Baylor College of Medicine, Houston, Texas 77030.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Texas</region>
</placeName>
<wicri:cityArea>Influenza Research Center, Baylor College of Medicine, Houston</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Six, H R" sort="Six, H R" uniqKey="Six H" first="H R" last="Six">H R Six</name>
</author>
<author><name sortKey="Cate, T R" sort="Cate, T R" uniqKey="Cate T" first="T R" last="Cate">T R Cate</name>
</author>
<author><name sortKey="Couch, R B" sort="Couch, R B" uniqKey="Couch R" first="R B" last="Couch">R B Couch</name>
</author>
</analytic>
<series><title level="j">Journal of virology</title>
<idno type="ISSN">0022-538X</idno>
<imprint><date when="1990" type="published">1990</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Animals, Newborn</term>
<term>Antibodies, Viral (analysis)</term>
<term>Cross Reactions</term>
<term>Female</term>
<term>Immunity, Maternally-Acquired</term>
<term>Influenza A virus (immunology)</term>
<term>Mice</term>
<term>Mice, Inbred Strains</term>
<term>Neutralization Tests</term>
<term>Orthomyxoviridae Infections (immunology)</term>
<term>Orthomyxoviridae Infections (prevention & control)</term>
<term>Pregnancy</term>
<term>Pregnancy, Animal (immunology)</term>
<term>Species Specificity</term>
<term>Vaccination</term>
<term>Vaccines, Attenuated</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Animaux nouveau-nés</term>
<term>Anticorps antiviraux (analyse)</term>
<term>Femelle</term>
<term>Gestation animale (immunologie)</term>
<term>Grossesse</term>
<term>Immunité acquise d'origine maternelle</term>
<term>Infections à Orthomyxoviridae ()</term>
<term>Infections à Orthomyxoviridae (immunologie)</term>
<term>Lignées consanguines de souris</term>
<term>Réactions croisées</term>
<term>Souris</term>
<term>Spécificité d'espèce</term>
<term>Tests de neutralisation</term>
<term>Vaccination</term>
<term>Vaccins atténués</term>
<term>Virus de la grippe A (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>Antibodies, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr"><term>Anticorps antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Gestation animale</term>
<term>Infections à Orthomyxoviridae</term>
<term>Virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza A virus</term>
<term>Orthomyxoviridae Infections</term>
<term>Pregnancy, Animal</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Orthomyxoviridae Infections</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Animals, Newborn</term>
<term>Cross Reactions</term>
<term>Female</term>
<term>Immunity, Maternally-Acquired</term>
<term>Mice</term>
<term>Mice, Inbred Strains</term>
<term>Neutralization Tests</term>
<term>Pregnancy</term>
<term>Species Specificity</term>
<term>Vaccination</term>
<term>Vaccines, Attenuated</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Animaux nouveau-nés</term>
<term>Femelle</term>
<term>Grossesse</term>
<term>Immunité acquise d'origine maternelle</term>
<term>Infections à Orthomyxoviridae</term>
<term>Lignées consanguines de souris</term>
<term>Réactions croisées</term>
<term>Souris</term>
<term>Spécificité d'espèce</term>
<term>Tests de neutralisation</term>
<term>Vaccination</term>
<term>Vaccins atténués</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">A single intraperitoneal injection of pregnant mice with a monovalent Formalin-inactivated influenza A virus vaccine protected their offspring against a lethal challenge dose of the same influenza A virus H3N2, H2N2, and H1N1 subtypes, as well as against challenge with the other two subtypes. Degree of protection was vaccine dose related. Cross-fostering of neonates indicated that protection was conferred by breast milk antibodies. Serum virus-specific neutralizing antibodies in the mothers and neonates correlated with resistance to vaccine virus, but were detected against other subtypes only in a complement enhancement test or when high doses of vaccine were given.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">2304146</PMID>
<DateCompleted><Year>1990</Year>
<Month>03</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-538X</ISSN>
<JournalIssue CitedMedium="Print"><Volume>64</Volume>
<Issue>3</Issue>
<PubDate><Year>1990</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
<Title>Journal of virology</Title>
<ISOAbbreviation>J. Virol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Vaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes.</ArticleTitle>
<Pagination><MedlinePgn>1370-4</MedlinePgn>
</Pagination>
<Abstract><AbstractText>A single intraperitoneal injection of pregnant mice with a monovalent Formalin-inactivated influenza A virus vaccine protected their offspring against a lethal challenge dose of the same influenza A virus H3N2, H2N2, and H1N1 subtypes, as well as against challenge with the other two subtypes. Degree of protection was vaccine dose related. Cross-fostering of neonates indicated that protection was conferred by breast milk antibodies. Serum virus-specific neutralizing antibodies in the mothers and neonates correlated with resistance to vaccine virus, but were detected against other subtypes only in a complement enhancement test or when high doses of vaccine were given.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mbawuike</LastName>
<ForeName>I N</ForeName>
<Initials>IN</Initials>
<AffiliationInfo><Affiliation>Influenza Research Center, Baylor College of Medicine, Houston, Texas 77030.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Six</LastName>
<ForeName>H R</ForeName>
<Initials>HR</Initials>
</Author>
<Author ValidYN="Y"><LastName>Cate</LastName>
<ForeName>T R</ForeName>
<Initials>TR</Initials>
</Author>
<Author ValidYN="Y"><LastName>Couch</LastName>
<ForeName>R B</ForeName>
<Initials>RB</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>N01-AI-62517</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Virol</MedlineTA>
<NlmUniqueID>0113724</NlmUniqueID>
<ISSNLinking>0022-538X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014613">Vaccines, Attenuated</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000831" MajorTopicYN="N">Animals, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003429" MajorTopicYN="N">Cross Reactions</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007112" MajorTopicYN="Y">Immunity, Maternally-Acquired</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008815" MajorTopicYN="N">Mice, Inbred Strains</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009500" MajorTopicYN="N">Neutralization Tests</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009976" MajorTopicYN="N">Orthomyxoviridae Infections</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011270" MajorTopicYN="N">Pregnancy, Animal</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014613" MajorTopicYN="Y">Vaccines, Attenuated</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1990</Year>
<Month>3</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1990</Year>
<Month>3</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1990</Year>
<Month>3</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">2304146</ArticleId>
<ArticleId IdType="pmc">PMC249259</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Infect Immun. 1975 May;11(5):908-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">47313</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 1983 Aug 11-17;304(5926):541-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6224092</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Hyg (Lond). 1978 Feb;80(1):13-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">621378</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 1977 Dec;136 Suppl:S686-92</Citation>
<ArticleIdList><ArticleId IdType="pubmed">606792</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Med. 1978 Apr 1;147(4):1236-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">306410</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 1979 Aug;140(2):141-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">479636</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 1979 Jul;10(1):32-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">227920</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 1979 Aug;10(2):184-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">583151</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Antimicrob Agents Chemother. 1980 Apr;17(4):642-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7396454</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Rev Infect Dis. 1980 May-Jun;2(3):408-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6997968</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 1980 Nov;125(5):2182-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7191866</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Epidemiol. 1981 Jan;113(1):12-21</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6257108</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Immunol. 1980 Nov;10(11):803-10</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6970126</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 1980 Dec;142(6):844-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7462695</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Scand J Immunol. 1980;12(5):393-400</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7466327</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 1980 Sep;12(3):426-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6260835</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Immunol. 1981 May 1;60(1):119-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6972261</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunol Rev. 1981;58:5-24</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6273293</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Obstet Gynecol. 1982 Jul 1;143(5):518-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7091222</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 1983 Feb;130(2):932-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6848601</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Immun. 1982 Dec;38(3):1249-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6295944</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 1984 Feb;132(2):928-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6606679</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 1984 Mar;81(6):1809-12</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6584913</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunology. 1984 Jul;52(3):389-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6745992</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 1985 May;21(5):847-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3839001</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Soc Exp Biol Med. 1986 Feb;181(2):298-304</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3945639</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 1986 Nov;60(2):614-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3773053</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunology. 1987 Jan;60(1):83-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3817868</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 1987 Sep 15;139(6):1985-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3114381</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 1987 Oct;68 ( Pt 10):2681-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3668509</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Microbios. 1988;54(220-221):135-47</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2846987</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Gen Virol. 1989 Jun;70 ( Pt 6):1523-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2732721</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Eur J Immunol. 1977 Sep;7(9):630-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">303568</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000455 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000455 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:2304146
   |texte=   Vaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:2304146" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a H2N2V1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021

	Serveur d'exploration H2N2
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration H2N2

Vaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes.

Vaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki